T1	DISO 87 102	migraña cronica
T2	PROC 125 193	Estudio de fase 3, aleatorizado, doble ciego, controlado con placebo
T3	CHEM 843 852	LY2951742
#1	AnnotatorNotes T3	C4742733; LY2951742; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	DISO 242 257	migraña crónica
T5	DISO 298 305	Migraña
#2	AnnotatorNotes T5	C0149931; Migraine Disorders; Disease or Syndrome
T6	DISO 332 347	Migraña Cronica
T7	PROC 433 444	Diagnóstico
#3	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	DISO 448 463	migraña crónica
T9	CHEM 881 885	CGRP
#4	AnnotatorNotes T9	C0006669; Calcitonin Gene-Related Peptide; Amino Acid, Peptide, or Protein · Hormone
T10	DISO 561 568	migraña
#5	AnnotatorNotes T10	C0149931; Migraine Disorders; Disease or Syndrome
T11	PROC 732 746	ensayo clínico
#6	AnnotatorNotes T11	C0008976; Clinical Trials; Research Activity
T12	CHEM 860 870	anticuerpo
#7	AnnotatorNotes T12	C0003241; Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T13	PROC 928 939	tratamiento
#8	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	PROC 958 966	prevenir
#9	AnnotatorNotes T14	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T15	DISO 971 979	migrañas
#10	AnnotatorNotes T15	C0149931; Migraine Disorders; Disease or Syndrome
T16	DISO 981 998	Hipersensibilidad
#11	AnnotatorNotes T16	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T17	CHEM 1010 1018	fármacos
#12	AnnotatorNotes T17	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T18	CHEM 1020 1044	anticuerpos monoclonales
#13	AnnotatorNotes T18	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T19	CHEM 1053 1075	proteínas terapéuticas
#14	AnnotatorNotes T19	C0872285; therapeutic protein; Pharmacologic Substance
T20	DISO 1134 1141	cefalea
#15	AnnotatorNotes T20	C0018681; Headache; Sign or Symptom
T21	DISO 1143 1161	cefalea en racimos
#16	AnnotatorNotes T21	C0009088; Cluster Headache; Disease or Syndrome
T22	DISO 1176 1183	migraña
#17	AnnotatorNotes T22	C0149931; Migraine Disorders; Disease or Syndrome
T23	DISO 1246 1268	migraña oftalmopléjica
#18	AnnotatorNotes T23	C0221058; Ophthalmoplegic Migraine; Disease or Syndrome
T24	DISO 1274 1290	migraña con aura
#19	AnnotatorNotes T24	C0154723; Migraine with Aura; Disease or Syndrome
T25	DISO 1311 1326	migraña basilar
#20	AnnotatorNotes T25	C0270860; Basilar-Type Migraine; Disease or Syndrome
T26	CHEM 215 224	LY2951742
#21	AnnotatorNotes T26	C4742733; LY2951742; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T27	DISO 1198 1217	migraña hemipléjica
#22	AnnotatorNotes T27	C0270862; Hemiplegic migraine; Disease or Syndrome
T28	CHEM 1081 1090	LY2951742
#23	AnnotatorNotes T28	C4742733; LY2951742; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T29	ANAT 1319 1326	basilar
#24	AnnotatorNotes T29	C0004811; Structure of basilar artery; Body Part, Organ, or Organ Component
T30	CHEM 60 69	LY2951742
#25	AnnotatorNotes T30	C4742733; LY2951742; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T31	PROC 73 83	prevención
#26	AnnotatorNotes T31	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T32	ANAT 1295 1309	troncoencéfalo
#27	AnnotatorNotes T32	C1306665; Entire brainstem; Body Part, Organ, or Organ Component
T33	Date 13 17	2015
T34	Duration 95 102	cronica
T35	LIVB 228 237	pacientes
#28	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Duration 250 257	crónica
#29	AnnotatorNotes T36	C0205191; chronic; Temporal Concept
T37	Duration 340 347	Cronica
T38	Age 374 384	18-65 años
T39	Duration 456 463	crónica
#30	AnnotatorNotes T39	C0205191; chronic; Temporal Concept
T40	Date 539 543	2013
T41	Age 582 589	50 años
T42	Duration 655 674	los 30 últimos días
T43	Duration 695 706	5 semividas
T45	Frequency 1122 1129	diarios
T44	CHEM 774 807	producto en fase de investigación
#31	AnnotatorNotes T44	C0013230; Investigational New Drugs; Pharmacologic Substance
A1	Status T11 History_of
A2	Assertion T13 Contraindicated
A3	Status T16 History_of
A4	Status T20 History_of
A5	Status T21 History_of
A6	Status T22 History_of
A7	Status T27 History_of
A8	Status T23 History_of
A9	Status T24 History_of
A10	Status T25 History_of
A11	Status T3 History_of
A12	Status T12 History_of
#32	AnnotatorNotes T37	C0205191; chronic; Temporal Concept
#33	AnnotatorNotes T34	C0205191; chronic; Temporal Concept
#34	AnnotatorNotes T1	C0744638; headache migraine chronic; Disease or Syndrome
#35	AnnotatorNotes T4	C0744638; headache migraine chronic; Disease or Syndrome
#36	AnnotatorNotes T6	C0744638; headache migraine chronic; Disease or Syndrome
#37	AnnotatorNotes T8	C0744638; headache migraine chronic; Disease or Syndrome
#38	AnnotatorNotes T2	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product
T46	Quantifier_or_Qualifier 943 952	permitido
A13	Assertion T46 Negated
#39	AnnotatorNotes T46	C0205540; Approved; Qualitative Concept
T47	Neg_cue 940 942	no
T48	Quantifier_or_Qualifier 1107 1119	persistentes
#40	AnnotatorNotes T48	C0205322; Persistent; Temporal Concept
R1	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T48	
R2	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T48	
R3	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T48	
R4	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T48	
R5	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T48	
R6	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T48	
R7	Location_of Arg1:T32 Arg2:T24	
R8	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T48	
R9	Has_Frequency Arg1:T20 Arg2:T45	
R10	Has_Frequency Arg1:T21 Arg2:T45	
R11	Has_Frequency Arg1:T22 Arg2:T45	
R12	Has_Frequency Arg1:T27 Arg2:T45	
R13	Has_Frequency Arg1:T23 Arg2:T45	
R14	Has_Frequency Arg1:T24 Arg2:T45	
R15	Has_Frequency Arg1:T25 Arg2:T45	
T49	Quantifier_or_Qualifier 1219 1229	esporádica
#41	AnnotatorNotes T49	C0205422; Sporadic (qualifier value); Temporal Concept
R16	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T49	
T50	Quantifier_or_Qualifier 1232 1240	familiar
#42	AnnotatorNotes T50	C0241888; Familial; Functional Concept 
R17	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T50	
R18	Used_for Arg1:T30 Arg2:T31	
R19	Has_Duration_or_Interval Arg1:T1 Arg2:T34	
R20	Experiences Arg1:T35 Arg2:T26	
R21	Has_Duration_or_Interval Arg1:T4 Arg2:T36	
R22	Experiences Arg1:T35 Arg2:T4	
R23	Has_Duration_or_Interval Arg1:T6 Arg2:T37	
T51	PROC 423 432	selección
#43	AnnotatorNotes T51	C0242802; Patient Selection; Research Activity
R24	Overlap Arg1:T51 Arg2:T38	
R25	Has_Duration_or_Interval Arg1:T8 Arg2:T39	
R26	Before Arg1:T10 Arg2:T41	
R29	Overlap Arg1:T44 Arg2:T42	
R30	Overlap Arg1:T44 Arg2:T43	
R31	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T46	
R32	Negation Arg1:T47 Arg2:T46	
R33	Before Arg1:T14 Arg2:T15	
R35	Causes Arg1:T17 Arg2:T16	
R36	Causes Arg1:T18 Arg2:T16	
R37	Causes Arg1:T19 Arg2:T16	
R38	Causes Arg1:T28 Arg2:T16	
R39	Location_of Arg1:T29 Arg2:T25	
T52	CONC 502 513	ICHD-3 beta
#44	AnnotatorNotes T52	[International Classification of Headache Disorders vs 3]
T53	CONC 531 537	ICHD-3
#45	AnnotatorNotes T53	[International Classification of Headache Disorders vs 3]
R40	Overlap Arg1:T53 Arg2:T40	
R41	Used_for Arg1:T52 Arg2:T7	
R42	Used_for Arg1:T53 Arg2:T7	
R43	Overlap Arg1:T52 Arg2:T40	
T54	CONC 1358 1369	ICHD-3 beta
#46	AnnotatorNotes T54	[International Classification of Headache Disorders vs 3]
T55	Observation 623 634;726 746	participado en un ensayo clínico
#47	AnnotatorNotes T55	C1278516; Patient participation status; Finding (?)
R44	Overlap Arg1:T55 Arg2:T42	
R27	Overlap Arg1:T55 Arg2:T43	
A14	Experiencer T35 Patient
